Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices.

BACKGROUND Recurrent paradoxical embolism after catheter-based closure of right-to-left shunt (RLS) can be related to residual RLS. To improve closure success, we need a better understanding of the anatomic and device-related factors associated with closure efficacy. METHODS Patients with cryptogenic neurologic events and severe RLS (Valsalva Spencer transcranial Doppler [TCD] grade 5/5+) who underwent patent foramen ovale (PFO) closure by either central pin (Amplatzer(®) PFO [A-PFO]) or central occluding (Amplatzer(®) SO [A-SO]) devices were evaluated for residual shunt by quantitative TCD evaluation at 3 months. The findings were correlated with atrial septal aneurysm (ASA), device type, and device size. RESULTS We closed 628 consecutive patients with either the A-PFO (n = 327) or A-SO (n = 301) device. The frequency of large defects, small defects, and ASA was 12%, 88%, and 44% of cases, respectively. Severe residual shunt was detected in 13% of A-PFO and 7% of A-SO recipients (P = 0.005). This difference was attributable to a much higher frequency of severe residual shunt among patients with large defects closed with the A-PFO compared to the A-SO device (12 out of 29 [41%] vs. 3 out of 42 [7%], respectively; P < 0.001). There was no significant difference in device failure frequency for small defects. The presence of ASA increased the frequency of severe residual shunt compared to those without this feature (36 out of 275 [13%] vs. 28 out of 353 [8%], respectively; P = 0.046) but did not influence device-related differences. CONCLUSIONS (1) Both noncentering and central occluding closure devices effectively reduce RLS after PFO closure. (2) Large PFO defects with or without ASA have lower residual shunt grades at 3 months when closed by central occluding devices.

[1]  F. Molinari,et al.  Follow‐up of residual shunt after patent foramen ovale closure , 2010, Acta neurologica Scandinavica.

[2]  J. Muhlestein,et al.  Transient neurological symptoms during contrast transcranial Doppler right-to-left shunt testing in patients with cryptogenic neurological disease. , 2010, Journal of interventional cardiology.

[3]  L. Roncon,et al.  Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure? , 2009, Journal of interventional cardiology.

[4]  C. McCollum,et al.  Transcranial Doppler detection of venous‐to‐arterial circulation shunts: Criteria for patent foramen ovale , 2009, Journal of clinical ultrasound : JCU.

[5]  R. Schnabel,et al.  Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm. , 2009, International journal of cardiology.

[6]  S. Carerj,et al.  Patent Foramen Ovale: Comparison among Diagnostic Strategies in Cryptogenic Stroke and Migraine , 2009, Echocardiography.

[7]  M. Schwerzmann,et al.  Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size. , 2009, JACC. Cardiovascular interventions.

[8]  B. Meier Stroke and migraine: a cardiologist’s headache , 2008, Heart.

[9]  A. Alexandrov,et al.  Detection of Right‐to‐Left Shunts: Comparison between the International Consensus and Spencer Logarithmic Scale Criteria , 2008, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[10]  J. Benbassat,et al.  Variability in duration of follow up may bias the conclusions of cohort studies of patients with patent foramen ovale , 2008, European journal of neurology.

[11]  N. Wunderlich,et al.  Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder). , 2008, The American journal of cardiology.

[12]  J. Carroll Migraine Intervention With STARFlex Technology trial: a controversial trial of migraine and patent foramen ovale closure. , 2008, Circulation.

[13]  M. Spence,et al.  Balloon assessment of patent foramen ovale morphology and the modification of tunnels using a balloon detunnelisation technique , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  C. Moy,et al.  Stroke Symptoms in Individuals Reporting No Prior Stroke or Transient Ischemic Attack Are Associated With a Decrease in Indices of Mental and Physical Functioning , 2007, Stroke.

[15]  J. V. Olsen,et al.  Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism. , 2007, The American journal of cardiology.

[16]  C. McCollum,et al.  Is Transcranial Doppler for the Detection of Venous-to-Arterial Circulation Shunts Reproducible? , 2007, Cerebrovascular Diseases.

[17]  D. Calvet,et al.  Do transient ischemic attacks with diffusion-weighted imaging abnormalities correspond to brain infarctions? , 2006, AJNR. American journal of neuroradiology.

[18]  C. McCollum,et al.  Young Adult Myocardial Infarction and Ischemic Stroke: the role of paradoxical embolism and thrombophilia (The YAMIS Study). , 2006, Journal of the American College of Cardiology.

[19]  F. Carreras,et al.  Almost Perfect Concordance Between Simultaneous Transcranial Doppler and Transesophageal Echocardiography in the Quantification of Right‐to‐Left Shunts , 2006, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[20]  V. Chair,et al.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the , 2006, Circulation.

[21]  T. Woods,et al.  A critical review of patent foramen ovale detection using saline contrast echocardiography: when bubbles lie. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[22]  M. DeRuiter,et al.  Morphogenetic Differences of Secundum Atrial Septal Defects , 2005, Pediatric Cardiology.

[23]  M. Schwerzmann,et al.  Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. , 2005, Journal of the American College of Cardiology.

[24]  J. V. Olsen,et al.  Power m-mode transcranial Doppler for diagnosis of patent foramen ovale and assessing transcatheter closure. , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[25]  M. Schwerzmann,et al.  Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. , 2004, Journal of the American College of Cardiology.

[26]  T. Marwick,et al.  Comparison of transcranial Doppler ultrasound and transesophageal contrast echocardiography in the detection of interatrial right-to-left shunts. , 1991, The American journal of cardiology.